Selected research
Industry Research
Cancer Registry Database Industry Research Report 2026
Market perspective
The global Cancer Registry Database market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cancer Registry Database market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cancer Registry Database market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cancer Registry Database market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cancer Registry Database include Elekta, Electronic Registry Systems, Onco, C/NET Solutions, Rocky Mountain Cancer Data Systems and McKesson Corporation, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cancer Registry Database market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cancer Registry Database.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cancer Registry Database Market by Company
Elekta
Electronic Registry Systems
Onco
C/NET Solutions
Rocky Mountain Cancer Data Systems
McKesson Corporation
Cancer Registry Database Segment by Type
Public Data
Commercial Data
Cancer Registry Database Segment by Application
Cloud-based
On-premises
Cancer Registry Database Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Registry Database market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cancer Registry Database and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Registry Database.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cancer Registry Database companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Public Data
- Commercial Data
Applications
- Cloud-based
- On-premises
Companies covered
- Elekta
- Electronic Registry Systems
- Onco
- C/NET Solutions
- Rocky Mountain Cancer Data Systems
- McKesson Corporation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cancer Registry Database by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Public Data
- 2.2.3 Commercial Data
- 2.3 Cancer Registry Database by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cloud-based
- 2.3.3 On-premises
- 2.4 Assumptions and Limitations
3 Cancer Registry Database Breakdown Data by Type
- 3.1 Global Cancer Registry Database Historic Market Size by Type (2021-2026)
- 3.2 Global Cancer Registry Database Forecasted Market Size by Type (2027-2032)
4 Cancer Registry Database Breakdown Data by Application
- 4.1 Global Cancer Registry Database Historic Market Size by Application (2021-2026)
- 4.2 Global Cancer Registry Database Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cancer Registry Database Market Perspective (2021-2032)
- 5.2 Global Cancer Registry Database Growth Trends by Region
- 5.2.1 Global Cancer Registry Database Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cancer Registry Database Historic Market Size by Region (2021-2026)
- 5.2.3 Cancer Registry Database Forecasted Market Size by Region (2027-2032)
- 5.3 Cancer Registry Database Market Dynamics
- 5.3.1 Cancer Registry Database Industry Trends
- 5.3.2 Cancer Registry Database Market Drivers
- 5.3.3 Cancer Registry Database Market Challenges
- 5.3.4 Cancer Registry Database Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cancer Registry Database Players by Revenue
- 6.1.1 Global Top Cancer Registry Database Players by Revenue (2021-2026)
- 6.1.2 Global Cancer Registry Database Revenue Market Share by Players (2021-2026)
- 6.2 Global Cancer Registry Database Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cancer Registry Database Head Office and Area Served
- 6.4 Global Cancer Registry Database Players, Product Type & Application
- 6.5 Global Cancer Registry Database Manufacturers Established Date
- 6.6 Global Cancer Registry Database Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cancer Registry Database Market Size (2021-2032)
- 7.2 North America Cancer Registry Database Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cancer Registry Database Market Size by Country (2021-2026)
- 7.4 North America Cancer Registry Database Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cancer Registry Database Market Size (2021-2032)
- 8.2 Europe Cancer Registry Database Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cancer Registry Database Market Size by Country (2021-2026)
- 8.4 Europe Cancer Registry Database Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cancer Registry Database Market Size (2021-2032)
- 9.2 Asia-Pacific Cancer Registry Database Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cancer Registry Database Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cancer Registry Database Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cancer Registry Database Market Size (2021-2032)
- 10.2 South America Cancer Registry Database Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cancer Registry Database Market Size by Country (2021-2026)
- 10.4 South America Cancer Registry Database Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cancer Registry Database Market Size (2021-2032)
- 11.2 Middle East & Africa Cancer Registry Database Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cancer Registry Database Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cancer Registry Database Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Elekta
- 12.1.1 Elekta Company Information
- 12.1.2 Elekta Business Overview
- 12.1.3 Elekta Revenue in Cancer Registry Database Business (2021-2026)
- 12.1.4 Elekta Cancer Registry Database Product Portfolio
- 12.1.5 Elekta Recent Developments
- 12.2 Electronic Registry Systems
- 12.2.1 Electronic Registry Systems Company Information
- 12.2.2 Electronic Registry Systems Business Overview
- 12.2.3 Electronic Registry Systems Revenue in Cancer Registry Database Business (2021-2026)
- 12.2.4 Electronic Registry Systems Cancer Registry Database Product Portfolio
- 12.2.5 Electronic Registry Systems Recent Developments
- 12.3 Onco
- 12.3.1 Onco Company Information
- 12.3.2 Onco Business Overview
- 12.3.3 Onco Revenue in Cancer Registry Database Business (2021-2026)
- 12.3.4 Onco Cancer Registry Database Product Portfolio
- 12.3.5 Onco Recent Developments
- 12.4 C/NET Solutions
- 12.4.1 C/NET Solutions Company Information
- 12.4.2 C/NET Solutions Business Overview
- 12.4.3 C/NET Solutions Revenue in Cancer Registry Database Business (2021-2026)
- 12.4.4 C/NET Solutions Cancer Registry Database Product Portfolio
- 12.4.5 C/NET Solutions Recent Developments
- 12.5 Rocky Mountain Cancer Data Systems
- 12.5.1 Rocky Mountain Cancer Data Systems Company Information
- 12.5.2 Rocky Mountain Cancer Data Systems Business Overview
- 12.5.3 Rocky Mountain Cancer Data Systems Revenue in Cancer Registry Database Business (2021-2026)
- 12.5.4 Rocky Mountain Cancer Data Systems Cancer Registry Database Product Portfolio
- 12.5.5 Rocky Mountain Cancer Data Systems Recent Developments
- 12.6 McKesson Corporation
- 12.6.1 McKesson Corporation Company Information
- 12.6.2 McKesson Corporation Business Overview
- 12.6.3 McKesson Corporation Revenue in Cancer Registry Database Business (2021-2026)
- 12.6.4 McKesson Corporation Cancer Registry Database Product Portfolio
- 12.6.5 McKesson Corporation Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst